<DOC>
	<DOCNO>NCT00460460</DOCNO>
	<brief_summary>The primary purpose study find maximum tolerate dose experimental drug call AZD4877 base side effect experience patient receive AZD4877 weekly basis disease .</brief_summary>
	<brief_title>Phase I , Open-label , Dose Escalation AZD4877 Hematologic Malignancies</brief_title>
	<detailed_description />
	<criteria>Patients AML , certain type ALL , NHL MM certain type cancer lymph node certain type leukemias ( blood cancer ) disease fail treatment relatively good overall health cancer poor bone marrow function ( produce enough blood cell ) serious heart condition poor liver kidney function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Phase I</keyword>
	<keyword>cancer</keyword>
	<keyword>lymphoma</keyword>
	<keyword>leukemia</keyword>
	<keyword>myeloma</keyword>
	<keyword>AML</keyword>
	<keyword>ALL</keyword>
	<keyword>NHL</keyword>
	<keyword>MM</keyword>
</DOC>